Investor Peizer Terren S
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Peizer Terren S . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-02-16 13G/A MULN / Mullen Automotive, Inc. 29,363,838 0
2022-03-10 13G/A MULN / Mullen Automotive, Inc. 11,363,838 29,363,838
2022-03-10 13D/A YAYO / EVmo, Inc. 11,294,699 12,487,019
2022-03-08 13D/A YAYO / EVmo, Inc. 3,230,512 11,294,699
2022-01-25 13G MULN / Mullen Automotive, Inc. 11,363,838
2021-11-02 13D/A OTRK / Ontrak, Inc. 9,114,155 9,114,155
2021-07-27 13D/A OTRK / Ontrak, Inc. 10,273,142 9,114,155
2021-06-11 13D/A BIVI / BioVie Inc. 11,168,538 19,529,846
2021-05-11 13D/A OTRK / Ontrak, Inc. 138,083,951 10,273,142
2021-05-10 13D/A BIVI / BioVie Inc. 11,168,538 11,168,538
2021-04-27 13D/A BIVI / BioVie Inc. 11,168,538 11,168,538
2021-02-16 13G/A LKCO / Luokung Technology Corp. 15,897,663 8,516,915
2021-02-04 13D YAYO / EVmo, Inc. 3,230,512 3,230,512
2020-09-23 13D/A BIVI / BioVie Inc. 547,241,666 11,168,538
2020-07-20 13G LKCO / Luokung Technology Corp. 15,897,663 15,897,663
2020-07-17 13G LKCO / Luokung Technology Corp. 15,897,663
2020-06-17 13G YAYO / EVmo, Inc. 3,230,512
2019-09-25 13D/A BIVI / BioVie Inc. 400,833,333 547,241,666
2019-07-19 13G ACST / Grace Therapeutics, Inc. 8,650,000
2019-04-08 13G CENN / Cenntro Inc. 2,934,455
2018-07-03 13D BIVI / BioVie Inc. 400,833,333
2014-02-14 13G/A TEUM / Pareteum Corp 0
2014-02-14 13G/A NAVB / Navidea Biopharmaceuticals, Inc. 3,169,015
2014-02-14 13G/A MVIS / MicroVision, Inc. 3,523,667
2013-09-26 13G NAVB / Navidea Biopharmaceuticals, Inc. 13,438,910
2013-06-24 13G TEUM / Pareteum Corp 10,630,498
2013-05-17 13G MVIS / MicroVision, Inc. 2,777,262
2013-02-14 13D/A OTRK / Ontrak, Inc. 138,083,951